rs200201449

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PP3BP6BS1BS2

The NM_004370.6(COL12A1):​c.5221G>A​(p.Glu1741Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00048 in 1,613,348 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00045 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00048 ( 2 hom. )

Consequence

COL12A1
NM_004370.6 missense

Scores

3
9
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 3.68
Variant links:
Genes affected
COL12A1 (HGNC:2188): (collagen type XII alpha 1 chain) This gene encodes the alpha chain of type XII collagen, a member of the FACIT (fibril-associated collagens with interrupted triple helices) collagen family. Type XII collagen is a homotrimer found in association with type I collagen, an association that is thought to modify the interactions between collagen I fibrils and the surrounding matrix. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
BP6
Variant 6-75138457-C-T is Benign according to our data. Variant chr6-75138457-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 475873.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=2}.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000453 (69/152288) while in subpopulation SAS AF= 0.00145 (7/4824). AF 95% confidence interval is 0.00068. There are 0 homozygotes in gnomad4. There are 31 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 2 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL12A1NM_004370.6 linkc.5221G>A p.Glu1741Lys missense_variant Exon 29 of 66 ENST00000322507.13 NP_004361.3 Q99715-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL12A1ENST00000322507.13 linkc.5221G>A p.Glu1741Lys missense_variant Exon 29 of 66 1 NM_004370.6 ENSP00000325146.8 Q99715-1

Frequencies

GnomAD3 genomes
AF:
0.000453
AC:
69
AN:
152170
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00720
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000368
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000842
AC:
209
AN:
248142
Hom.:
1
AF XY:
0.000877
AC XY:
118
AN XY:
134586
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000496
Gnomad ASJ exome
AF:
0.00630
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00135
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000710
Gnomad OTH exome
AF:
0.00133
GnomAD4 exome
AF:
0.000483
AC:
705
AN:
1461060
Hom.:
2
Cov.:
31
AF XY:
0.000527
AC XY:
383
AN XY:
726764
show subpopulations
Gnomad4 AFR exome
AF:
0.0000598
Gnomad4 AMR exome
AF:
0.000449
Gnomad4 ASJ exome
AF:
0.00529
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00115
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000350
Gnomad4 OTH exome
AF:
0.000762
GnomAD4 genome
AF:
0.000453
AC:
69
AN:
152288
Hom.:
0
Cov.:
32
AF XY:
0.000416
AC XY:
31
AN XY:
74470
show subpopulations
Gnomad4 AFR
AF:
0.000120
Gnomad4 AMR
AF:
0.000392
Gnomad4 ASJ
AF:
0.00720
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00145
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000368
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000904
Hom.:
0
Bravo
AF:
0.000514
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.000262
AC:
1
ESP6500EA
AF:
0.000843
AC:
7
ExAC
AF:
0.000803
AC:
97
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.000764
EpiControl
AF:
0.00101

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Jun 01, 2016
CeGaT Center for Human Genetics Tuebingen
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 09, 2021
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Uncertain:1
Dec 17, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: COL12A1 c.5221G>A (p.Glu1741Lys) results in a conservative amino acid change located in the Fibronectin type III domain (IPR003961) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00084 in 248142 control chromosomes in the gnomAD database, including 1 homozygotes. This frequency is not significantly higher than estimated for a pathogenic variant in COL12A1 causing Ullrich congenital muscular dystrophy 2 (0.00084 vs 0.0035), allowing no conclusion about variant significance. To our knowledge, no occurrence of c.5221G>A in individuals affected with Ullrich congenital muscular dystrophy 2 and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 475873). Based on the evidence outlined above, the variant was classified as uncertain significance. -

Bethlem myopathy 2;C4225314:Ullrich congenital muscular dystrophy 2 Benign:1
Jan 21, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Uncertain
0.091
D
BayesDel_noAF
Pathogenic
0.32
CADD
Pathogenic
32
DANN
Uncertain
1.0
DEOGEN2
Benign
0.026
T;T;.;.;.
Eigen
Uncertain
0.47
Eigen_PC
Uncertain
0.50
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Pathogenic
0.98
D;D;D;D;D
M_CAP
Benign
0.057
D
MetaRNN
Benign
0.036
T;T;T;T;T
MetaSVM
Uncertain
0.28
D
MutationAssessor
Pathogenic
3.0
.;M;.;M;.
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-1.4
.;N;N;N;N
REVEL
Uncertain
0.59
Sift
Benign
0.031
.;D;D;D;D
Sift4G
Uncertain
0.028
D;D;D;D;D
Polyphen
0.81, 0.88
.;P;P;.;.
Vest4
0.71
MVP
0.96
MPC
0.60
ClinPred
0.068
T
GERP RS
5.8
Varity_R
0.24
gMVP
0.67

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.78
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.78
Position offset: 3

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200201449; hg19: chr6-75848173; COSMIC: COSV99072102; COSMIC: COSV99072102; API